Contralateral but not systemic administration of the κ-opioid agonist U-50,488H induces anti-nociception in acute hindpaw inflammation in rats

British Journal of Pharmacology

Volumn 132, Issue 1, 2001, Pages 252-258

  Bileviciute Ljungar, Indre ^a   Spetea, Mariana ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute inflammation; Contralateral treatment; Nociception; Oedema; Opioid receptors; U 50,488H; opioid agonist

Indexed keywords

17 METHYLNALOXONE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; CARRAGEENAN; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; OPIATE ANTAGONIST; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENERVATION; DRUG ACTIVITY; DRUG ANTAGONISM; INFLAMMATION; MALE; NOCICEPTION; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; SCIATIC NERVE;

EID: 0035141564     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703782     Document Type: Article

References (29)

1. Perineural defect and peripheral opioid analgesia in inflammation
2. Opiate agonists inhibit neurogenic plasma extravasation in the rat
3. Unilateral injection of calcitonin-gene-related peptide (CGRP) induces bilateral oedema formation and release of CGRP-like immunoreactivity
4. Contralateral but not systemic administration of bupivacaine reduces acute inflammation in the rat hindpaw
5. Contralateral treatment with xylocaine reduces nociceptive behaviour in mononeuropathic rats
6. Potentiation of tachykinin-induced plasma protein extravasation by calcitonin gene-related peptide
7. Decrease of substance P in primary afferent neurones and impairment of neurogenic plasma extravasation by capsaicin
8. Experimental evidence on the nature of cutaneous hyperalgesia
9. Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue
10. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin
11. Pain and analgesia
12. Opioid and nonopioid analgesic agents: Some aspects of central (spinal) and peripheral actions
13. Axonal transport of opiate receptors in capsaicin-sensitive neurones
14. Opioid control of the function of primary afferent substance P fibres
15. 5)enkephalinamide
16. Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves
17. Pain mechanisms: A new theory
18. Multiple opioid systems and pain
19. Effect of neurokinin A, substance P and calcitonin gene-related peptide in peripheral hyperalgesia in the rat paw
20. Opiates inhibit the discharges of the fine afferent units from inflamed knee joint of the cat
21. Peripheral opioid receptors located on the rat saphenous nerve
22. The treatment of persistent pain of organic origin in the lower part of the body by division of the anterolateral column of the spinal cord
23. Peripheral mechanisms of opioid analgesia
24. Local analgesic effect of endogenous opioid peptides
25. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation
26. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of Mu, Delta and Kappa receptors
27. Antinociceptive effects of μ- and κ-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanism
28. No tolerance to peripheral analgesia in presence of opioid expression in inflamed synovia
29. Heterogenous sensitivity of cultured dorsal root ganglion neurones to opioid peptides selective for μ- and δ-opioid receptors